Enzolytics Inc (ENZC)

[oodtw]

..the snippet below from the REGN PR clearly means 'independently' of BARDA, not independently all by themselves without any outside help...

Under the project structure, Regeneron independently invents and proposes an antibody candidate, which BARDA and Regeneron will then evaluate and agree upon for further development, manufacturing and regulatory activities. Regeneron’s most advanced next-generation antibody candidate under this agreement is expected to enter clinical trials later this year.